You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 16, 2025

Details for New Drug Application (NDA): 210424

✉ Email this page to a colleague

« Back to Dashboard

NDA 210424 describes METHYLERGONOVINE MALEATE, which is a drug marketed by Am Regent, Breckenridge, Amneal Pharms, Chartwell Rx, Granules, Rising, Teva Pharms Usa, and Tp Anda Holdings, and is included in eight NDAs. It is available from thirteen suppliers. Additional details are available on the METHYLERGONOVINE MALEATE profile page.

The generic ingredient in METHYLERGONOVINE MALEATE is methylergonovine maleate. There is one drug master file entry for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the methylergonovine maleate profile page.

Summary for 210424

Tradename:	METHYLERGONOVINE MALEATE
Applicant:	Granules
Ingredient:	methylergonovine maleate
Patents:	0

Pharmacology for NDA: 210424

Medical Subject Heading (MeSH) Categories for 210424

Oxytocics

Suppliers and Packaging for NDA: 210424

Tradename	Generic Name	Dosage	NDA	Application Type	Supplier	National Drug Code	Package Code	Package
METHYLERGONOVINE MALEATE	methylergonovine maleate	TABLET;ORAL	210424	ANDA	Major Pharmaceuticals	0904-7282	0904-7282-10	20 BLISTER PACK in 1 CARTON (0904-7282-10) / 1 TABLET in 1 BLISTER PACK
METHYLERGONOVINE MALEATE	methylergonovine maleate	TABLET;ORAL	210424	ANDA	American Health Packaging	60687-813	60687-813-94	20 BLISTER PACK in 1 CARTON (60687-813-94) / 1 TABLET in 1 BLISTER PACK (60687-813-11)

Profile for product number 001

Active Rx/OTC/Discontinued:	RX	Dosage:	TABLET;ORAL			Strength	0.2MG
Approval Date:	May 15, 2018	TE:	AB	RLD:	No

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.